Sonnet BioTherapeutics
SONN
SONN
18 hedge funds and large institutions have $509K invested in Sonnet BioTherapeutics in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
18
Holders Change
-2
Holders Change %
-10%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
TDC
1
Thompson Davis & Co
Richmond,
Virginia
|
$17K |
2 |
2
Stifel Financial
St. Louis,
Missouri
|
$0 |
3 |
3
Citadel Advisors
Miami,
Florida
|
$0 |
4 |
4
Barclays
London,
United Kingdom
|
$2K |